https://www.selleckchem.com/pr....oducts/Temsirolimus.
Prevention and prediction of microvascular complications are important aims of medical care in people with type 1 diabetes. Since the course of the disease is heterogenous, we tried to identify subgroups with specific risk profiles for microvascular complications. Retrospective analysis of a cohort of 285 people (22637 consultations) with 10 years of type 1 diabetes. Persons were grouped into slow (15 years), fast (15 years) and non progressors according to the average onset of microvascular complications. Generalized e
إعجاب
علق
شارك
